CURRICULUM VITAE
Professor Donna L. Lamping
ADDRESS
CITIZENSHIP
Health Services Research Unit
Department of Public Health and Policy
London School of Hygiene & Tropical Medicine
Keppel Street
London WC1E 7HT, UK
Canadian
Tel: +44 (0)20 7927 2380
Fax: +44 (0)20 7580 8183
E-mail: donna.lamping@lshtm.ac.uk
Skype: dlamping
EDUCATION
1981
PhD (Psychology), Harvard University (Doctoral thesis: Psychosocial adaptation and adjustment to the
stress of chronic illness)
1976
Honours BA (Psychology), University of Waterloo
ACADEMIC APPOINTMENTS
1992Professor of Psychology, Health Services Research Unit, Department of Public Health and Policy, London
School of Hygiene & Tropical Medicine, London, UK
2003-06 Research Degrees Pgm Director, 1999-02 Head, Health Services Research Unit
1988-91
Assistant Professor, Department of Epidemiology and Biostatistics, McGill University, Montreal, QC
1986-88
Assistant Professor, Department of Psychology, Fordham University, Bronx, NY
1982-86
Assistant Professor, Department of Psychology, McMaster University, Hamilton, ON
1981-82
Lecturer & Research Associate, Dept Psychology & Social Relations, Harvard University, Cambridge, MA
RESEARCH INTERESTS
Measurement in health care research; patient-reported outcomes/quality of life; psychometric theory and methods;
health technology assessment.
CURRENT RESEARCH GRANTS AND CONSULTANCIES
2009Outcome Measurement Consultancy, Eisai Corporation, Patient-reported outcome evidence needs,
including health-related quality of life, for Eisai’s product portfolio
2009-10
Principal Investigator (DL Lamping), Eisai Corporation, Systematic search of the literature to identify
papers for systematic review of disease-specific HRQoL instruments in diabetic peripheral neuropathyStage 1 (£4,999)
2009-13
Co-Investigator (A Templeton, T Mahmood, I Gurol-Uganci, D Cromwell, J van der Meulen et al.), The
Healthcare Quality Improvement Partnership, An audit of patient outcomes and experience of treatment
for women with heavy menstrual bleeding (£1,252,253)
2008Advisory Board Consultancy, AstraZeneca, Key Opinion Leader services in the area of analgesia with a
specific focus on Patient Reported Outcomes (PROs) to continuously review AstraZeneca’s strategies for
AZD1386, MEDI578 and AZD2066 ($16,000USD)
2008-09
Co-Investigator (S Banerjee, J Brazier, DL Lamping, S Smith, M Knapp, R Howard, T Young),
NHS Research and Development, Health Technology Assessment Programme, Generation of preferencebased indices from DEMQOL and DEMQOL-Proxy for use in economic evaluation (£495,595)
2008-09
Co-Investigator (C Lavy, Y Alavi, DL Lamping, S Hartley, S Smith), Christian Blind Mission, CURE
International. Malawi Outcome Project - Phase I (£57,000)
2008-12
Co-Investigator (J Nixon, S Linter, J Hansford, J Brown, DL Lamping, J Keen, C McCabe, A Nelson, M
Briggs, E McGinnis, C Dealey, G Worthy), National Institute for Health Research Programme Grants,
NIHR Pressure Ulcer Programme (£1,999,834)
2006-10
Principal Investigator, Bayer HealthCare Pharma, Psychometric validation of the Anti-Clot Treatment Scale
(ACTS) in venous thromboembolism and atrial fibrillation (£100,720)
DIALYSIS-RELATED PUBLICATIONS
Oliver, M.J., Quinn, R.R., Richardson, E.P., Kiss, A., Lamping, D.L. et al. (2007). Home care assistance and the
utilization of peritoneal dialysis. Kidney International, 71, 673-8.
Roderick, P., Nicholson, T., Armitage, A., Mehta, R., Mullee, M., Gerard, K., Drey, N., Feest, T., Greenwood, R.,
Lamping, D.L. et al. (2005). An evaluation of the costs, effectiveness and quality of renal replacement therapy provision
in renal satellite units in England and Wales. Health Technology Assessment, 9 (24).
Roderick, P., Armitage, A., Nicholson, T., Mehta, R., Gerard, K., Mullee, M., Drey, N., Lamping, D., Feest, T.,
Greenwood, R., & Townsend, J. (2004). A clinical and cost evaluation of hemodialysis in renal satellite units in England
and Wales. American Journal of Kidney Diseases, 43, 121-31.
Lamping, D.L. Health-related quality of life in chronic renal failure. (2004). In E. J. Chambers, M. Germain, E. Brown
(Eds.), Supportive care for the renal patient (pp. 63-74). Oxford: Oxford University Press.
Gruen, R.P., Constantinovici, N., Normand, C., & Lamping, D.L. for the North Thames Dialysis Study (NTDS) Group.
(2003). Costs of dialysis for elderly people in the UK. Nephrology, Dialysis and Transplantation, 18, 2122-7.
Harris, S.A.C., Lamping, D.L., Constantinovici, N., Brown, E.A. for the NTDS Group (2002). Clinical outcomes and
quality of life in elderly patients on peritoneal dialysis versus haemodialysis. Peritoneal Dialysis Int’l, 22, 463-70.
2
Lamping, D.L. (2002). Health-related quality of life in elderly people on dialysis. Br J Renal Medicine, Spring, 21-4.
Lamping, D.L., Roderick, P., & Brown, E. for the North Thames Dialysis Study (NTDS) Group. (2001). North Thames
Dialysis Study [Letter]. Lancet, 357, 719-20.
Lamping, D.L., Roderick, P., Brown, E., & Normand, C. for the NTDS Group. (2001). Why age should not be a barrier
to dialysis: Implications of the North Thames Dialysis Study. NHS Trusts 2001 Commissioners' Guide, 85-7..
Lamping, D.L., Constantinovici, N., Roderick, P., Normand, C., Henderson, L., Harris, S., Brown, E., Gruen, R., &
Victor, C. (2000). Clinical outcomes, quality of life and costs in the North Thames Dialysis Study of elderly people on
dialysis: A prospective cohort study. Lancet, 356, 1543-50.
Lamping, D.L., & Campbell, K.A. (1990). Hemodialysis compliance: Assessment, prediction, and intervention -Part II.
Seminars in Dialysis, 3, 105-11.
Lamping, D.L., & Campbell, K.A. (1990). Hemodialysis compliance: Assessment, prediction, and intervention - Part I.
Seminars in Dialysis, 3, 52-6.
Lamping, D.L., & Campbell, K.A. (1989). A methodological study of hemodialysis compliance criteria. Journal of
Compliance in Health Care, 4, 117-34.
Maher, B.A., Lamping, D.L., Dickinson, C.A., Murawski, B.J., Olivier, D.C., & Santiago, G.C. (1983). Psychosocial
aspects of chronic hemodialysis: The National Cooperative Dialysis Study. Kidney International, 23, S50-7.
OTHER PUBLICATIONS - PEER-REVIEWED JOURNAL ARTICLES (2006-09 only)
Browne, J.P., van der Meulen, J.H., Lewsey, J.D., Lamping, D.L. et al. (in press). Mathematical coupling may account
for the association between baseline severity and minimally important difference values. J Clinical Epidemiology.
Hilari, K., Lamping, D.L. et al. (2009). Psychometric properties of the Stroke and Aphasia Quality of Life Scale
(SAQOL-39) in a generic stroke population. Clinical Rehabilitation, 23, 544-57.
Kahn, S.R., Shrier, I., Julian, J.A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F.,
Kassis, J., Solymoss, S., Desjardins, L., Lamping, D.L. et al. (2008). Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Annals of Internal Medicine, 149, 698-707.
Kahn, S.R., Shbaklo, H., Lamping et al. (2008). Determinants of health-related quality of life during the 2 years
following deep venous thrombosis. Journal of Thrombosis and Haemostasis, 6, 1105-12.
Dasgupta, B., Hutchings, A., Hollywood, J., & Nutter, L. for the PMR Outcomes Group. (2008). Autoantibodies to cyclic
citrullinated peptide in a PMR inception cohort from the PMR Outcomes Study. Annals Rheum Diseases, 67, 903-4.
Quinn, R.R., Lamping, D.L. et al. (2008). The Vascular Access Questionnaire: assessing patient-reported views of
vascular access. Journal of Vascular Access, 9, 122-8.
Zowall, H., Cairns, J.A., Brewer, C., Lamping, D.L. et al. (2008). Cost-effectiveness of magnetic resonance-guided
focused ultrasound surgery for treatment of uterine fibroids. British Journal of Obstetrics & Gynaecology, 115, 653-62.
Hutchings, A., Hollywood, J., Lamping, D.L., et al. (2007). Clinical outcomes, quality of life and diagnostic uncertainty in
the first year of polymyalgia rheumatica. Arthritis & Rheumatism, 57, 803-9.
Smith, S.C., Lamping, D.L. et al. (2007). Development of a new measure of health-related quality of life for people with
dementia: DEMQOL. Psychological Medicine, 37, 737-46.
Schroter, S., & Lamping, D.L. (2006). Responsiveness of the Coronary Revascularisation Outcome Questionnaire
compared with the SF-36 and Seattle Angina Questionnaire. Quality of Life Research, 15, 1069-78.
Kahn, S.R., Lamping, D.L. et al. (2006). VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific
quality of life measure for deep venous thrombosis. Journal of Clinical Epidemiology, 59, 1049-56.
Guarino, P., Lamping, D.L. et al. (2006). Assessment of study participants’ self-reported level of understanding of
informed consent in a randomized clinical trial: Evaluation of acceptability, reliability and validity. Journal of Clinical
Epidemiology, 59, 608-14.
Banerjee, S., Smith, S.C., Lamping, D.L. et al. (2006). Quality of life in dementia: more than just cognition. An analysis
of associations with quality of life in dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 77, 146-8.
Cano, S.J., Browne, J.P., Lamping, D.L. et al. (2006). The Patient Outcomes of Surgery-Head/Neck (POSHead/Neck): A new patient-based outcome measure. J Plastic, Reconstructive & Aesthetic Surgery, 59, 65-73.
SCIENTIFIC ACTIVITIES: INTERNATIONAL AND NATIONAL (2006-09 only)
2006-09
President, International Society for Quality of Life Research (President-Elect 2006-07; President 2007-08;
Past President 2008-09) and Member, Executive Committee
2007-08
Member, Review Panel, Macmillan Cancer Support Postdoctoral Fellowships
2007Member, Review Panel, Joint British Renal Society/Kidney Research UK Fellowship
2007Member, College of Panellists (formerly Expert Sub-Panel), National Institute for Health Research
Programme Grants for Applied Research
2006-07
Member, Scientific Programme Committee, 14th Annual Conference of the International Society for Quality of
Life Research, Toronto
2007
Chair, Conference on Outcome measurement: Shifting the focus from outputs to outcomes (Organiser:
Health Service Journal, London)
2006Member, Research Grants Committee, Kidney Research UK
2006Member, Review Panel, PhD Scholars Programme, Health Research Board, Dublin
2005-07
Member, European Quality of Life Pressure Ulcer Instrument Project (EQUIP) Collaborative Group, Smith
and Nephew Foundation
3
2005-06
2005-06
2005
2004-07
2004-07
2003-07
200320001998-
Member, US and European Advisory Boards, Development of Patient-Reported Outcome Measures in Acute
Exacerbations of Chronic Obstructive Pulmonary Disease, GlaxoSmithKline
Member, Steering Group, London Hub of UK GRAD Programme
Member, Expert Review Panel, National Cancer Research Institute Supportive and Palliative Care
Research Collaboratives
Expert Advisor, Recommendations for Approach to Patient-Reported Outcome (PRO) Assessment in Phase
III trials in VTE Prevention and Treatment with Bay 59-7939, Bayer plc
Member, Steering Committee, Assessing Health-Related Quality of Life after Stroke, Health Foundation
Member, Steering Committee, HOME PLUS Study, Institute for Clinical and Evaluative Sciences,
Sunnybrook and Women’s College Health Sciences Centre, Change Foundation
Expert Advisory Network, Health Technology Assessment Pgm, NHS Research & Development Pgm
Member, Scientific Review Committee, British Renal Society, Research Initiatives Group
Editorial Board, Psychology, Health & Medicine
CV short nov09.DLL